• A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-Associated Liver Disease
• A case of adrenal Castleman disease combined with liver cirrhosis and splenomegaly
• A novel model based on serum N-glycan markers for evaluating stage of liver necroinflammation in treatment-naive chronic hepatitis B patients
• A simple model to predict early recurrence of hepatocellular carcinoma after liver resection
• Acute Kidney Injury in Chronic Liver Disease in Northwest India: Still a Battle to Conquer
• ALKALINE PHOSPHATASE AND LIVER FIBROSIS AT DIAGNOSIS ARE ASSOCIATED WITH DEEP RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS
• Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis
• Assessment of gnostic and stereognostic functions in patients with liver cirrhosis: A comparative study with healthy controls
• Assessment of Liver Involvement in Patients With Type 2 Diabetes Mellitus in Basrah City, Iraq, Using FibroScan and Correlation With Risk Factors
• Association of serum lipid profile with liver fibrosis in HCV-coinfected HIV patients on suppressive anti-retroviral therapy
• Biomechanical Assessment of Liver Integrity: Prospective Evaluation of Mechanical Versus Acoustic MR Elastography
• Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation
• Causal effects of autoimmune diseases on thyroid cancer: a two-sample Mendelian randomization study
• Causal Effects of Smoking, Alcohol Consumption, and Coffee Intake on Hepatobiliary and Pancreatic Diseases: A Mendelian Randomization Study
• Characteristics and antiviral treatment eligibility of patients diagnosed with hepatitis B at a teaching hospital in Ghana: Implications for prevention and management
• Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
• Contemporary Awareness of Nonalcoholic Fatty Liver Disease and Viral Hepatitis Based on the Stage
• Cross-tissue organization of myeloid cells in scleroderma and related fibrotic diseases
• Cryptococcus neoformans fungemia in a liver transplant patient: case report and literature review
• Cysteine sulfenylation contributes to liver fibrosis via the regulation of EphB2-mediated signaling
• Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis
• Demographics and outcomes of patients younger than 75 years undergoing aortic valve interventions in Rotterdam
• Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis
• Diagnostic Accuracy of Transient Elastography for Staging Liver Fibrosis in Autoimmune Liver Diseases: A Systematic Review and Meta-Analysis
• Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
• Eicosapentaenoic acid administration ameliorates the progression of liver fibrosis after laparoscopic Kasai portoenterostomy
• Endogenous PGD2 acting on DP2 receptor counter regulates Schistosoma mansoni infection-driven hepatic granulomatous fibrosis
• Epidemiology and risk factors for angiodysplasias of the upper and lower gastrointestinal tract: A large population-based study
• Epidemiology of Metabolic Dysfunction Associated Steatotic Liver Disease
• Establishment and Evaluation of a Noninvasive Metabolism-Related Fatty Liver Screening and Dynamic Monitoring Model: Cross-Sectional Study
• Evaluating Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedure among Native Americans
• Experimental study on H(2)O(2) activation of HSC-T6 and hepatic fibrosis in cholestatic mice by "Yajieshaba"
• Exploring novel A_2AAR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents
• Exploring the cytoprotective role of mesenchymal stem Cell-Derived exosomes in chronic liver Fibrosis: Insights into the Nrf2/Keap1/p62 signaling pathway
• Expression of Vascular Adhesion Protein-1 and Thrombospondin-1 in Gingival Crevicular Fluid of Patients with Periodontitis and Non-Alcoholic Fatty Liver Disease
• Factors associated with pre-treatment hyperferritinemia in patients with chronic hepatitis C virus infection
• Far-infrared radiation alleviates steatohepatitis and fibrosis in metabolic dysfunction-associated fatty liver disease
• From MASLD to HCC: What's in the middle?
• FTO-mediated m (6)A demethylation of ULK1 mRNA promotes autophagy and activation of hepatic stellate cells in liver fibrosis
• GSK805 inhibits alpha-smooth muscle expression and modulates liver inflammation without impairing the well-being of mice
• Hepatitis B Virus Treatment in Children: Common Challenges and Management Options in a Case-Based Format
• Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress
• Hepatoprotective effects of diosmin: a narrative review
• Higher In-Hospital Mortality among Asian Americans Undergoing Transjugular Intrahepatic Portosystemic Shunt Procedure
• Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis
• Identification of microbial antigens in liver tissues involved in the pathogenesis of primary biliary cholangitis using 16S rRNA metagenome analysis
• Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
• Impact of hepatic resection in the treatment of hepatocellular carcinoma
• Impacts of smoking on alcoholic liver disease: a nationwide cohort study
• Incidence of liver complications with hemochromatosis associated HFE p.C282Y homozygosity: The role of central adiposity
• Informatics driven solutions for optimal care delivery in liver transplantation
• Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia
• Intrinsic Causes of Nonfibrotic Portal Hypertension-A Clinicopathologic Review of 56 Patients
• Inverse association between lung function and nonalcoholic fatty liver disease: An observational and mendelian randomization study
• Lactucin reverses liver fibrosis by inhibiting TGF-beta1/STAT3 signaling pathway and regulating short-chain fatty acids metabolism
• Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
• Liver Stiffness and Steatosis Measurements with iLivTouch and FibroScan: A Comparative Study
• Metabolic characteristics of patients with MetALD: Caveats of a new definition
• Metabolic Dysfunction-Associated Fatty Liver Disease and Fibrosis Status in Patients with Type 2 Diabetes Treated at Internal Medicine Clinics: Turkiye DAHUDER Awareness of Fatty Liver Disease (TR-DAFLD) Study
• MRI paraspinous skeletal muscle enhancement: A potential imaging biomarker for assessing clinical liver cirrhosis severity
• Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis
• NLRP3 inflammasome inhibition decreases Schistosomiasis japonica-induced granulomatous inflammation and fibrosis in BALB/c mice
• NLRP3 inflammasome pathway involved in the pathogenesis of metabolic associated fatty liver disease
• Non-pharmacological Interventions for Muscle Cramps and Pain in Patients With Cirrhosis: A Systematic Review
• Novel Vibrio vulnificus sequence type 540 infection in a hepatitis patient
• Obstructive Sleep Apnea and Medical Comorbidities in the Asian Population: Evidence From a Nationwide Healthcare System Data in South Korea
• PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis
• Pediatric Combined Heart-liver Transplantation: A Single-center Long-term Experience
• PF127/bleomycin hydrogel promotes subcutaneous extracellular matrix remodeling and fibrosis to construct personalized flaps through the TGFbeta-Col signaling pathway
• PPARbeta/delta attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells
• Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists
• Prognostic factors in patients with intrahepatic cholangiocarcinoma
• Protein-losing enteropathy as a result of colon polyposis and colon cancer: a multidisciplinary approach to diagnosis and treatment
• Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks
• Quadruple Complication in a Patient With Liver Cirrhosis: A Diagnostic Conundrum
• Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
• Reply to: Correspondence on "Cardiomyopathy in cirrhosis: From pathophysiology to clinical care"
• Reply to: Does encephalopathy with early onset after TIPS impact on mortality?
• Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment
• Role of multiparametric US in the preoperative assessment of hepatic parenchyma in patients with liver tumors
• Role of peripheral inflammation in minimal hepatic encephalopathy
• Role of TGFβ-producing regulatory T cells in scleroderma and end-stage organ failure
• Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease
• Rosacea and autoimmune liver diseases: a two-sample Mendelian randomization study
• Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery
• Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment
• Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study
• Targeting the liver clock improves fibrosis by restoring TGF-beta signaling
• Temporal evolution of living donor liver transplantation survival - A UNOS registry study
• The impact of restrictive blood transfusion on the safety of patients with esophageal varices after endoscopic variceal ligation: A single-center retrospective study
• The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
• The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols
• Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29-year follow-up
• Trimethylamine N-oxide induces non-alcoholic fatty liver disease by activating the PERK
• Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
• Type 1 diabetes and combined acute and chronic complications are associated with risk of progression of liver fibrosis: a Mendelian randomization study
• Understanding acute kidney injury (AKI) in liver cirrhosis from the acute-on-chronic liver failure (ACLF) perspective
• Unveiling Endogenous Serum Peptides as Potential Biomarkers for Hepatocellular Carcinoma in Patients with Liver Cirrhosis
• US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study
• Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma